Medical Bulletin 14/ September/ 2024 Dr. Garima Soni14 Sept 2024 3:00 PM ISTHere are the top medical news for the day:No more BP Cuff? Researchers Developing Android App for Blood Pressure MonitoringResearchers at the...
Obesity Paradox In Cancer Therapy? JAMA Study Explores to Find the Link Dr. Garima Soni14 Sept 2024 8:30 AM ISTWhile being overweight increases the risk of developing lifestyle-related diseases, there is a phenomenon known as the obesity paradox where a...
Immunotherapy before and after lung cancer surgery reduces death risk, disease recurrence, finds study Dr. Kamal Kant Kohli11 Sept 2024 3:30 AM ISTPeople with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after...
COPD and Asthma May Hide Early Lung Cancer Symptoms, Causing Diagnosis Delays: Study Reveals sheeba farhat2 Sept 2024 8:30 AM ISTA recent study in the British Journal of Cancer indicates that patients with specific long-term health conditions might experience delays in receiving...
Merck scraps two late-stage trials of cancer drug Keytruda MD Bureau Team31 Aug 2024 12:45 PM ISTLondon: Merck has stopped two separate late-stage studies of its immunotherapy Keytruda in patients with skin and lung cancers, the company said on...
Lung cancer drug: Natco Pharma submits ANDA for generic version of Novartis Tabrecta Ruchika Sharma30 Aug 2024 11:04 AM ISTHyderabad: Natco Pharma Limited has announced its submission of an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification...
Rheumatoid arthritis was linked to increased risk of lung cancer: Study Jacinthlyn Sylvia22 Aug 2024 10:30 PM ISTA new study published in the journal of Arthritis & Rheumatology observed an almost 3-fold greater risk of lung cancer was related with rheumatoid...
AstraZeneca Imfinzi in combo with chemotherapy gets USFDA approval for treatment of resectable non-small cell lung cancer before and after surgery Ruchika Sharma17 Aug 2024 1:30 PM ISTCambridge: AstraZeneca's Imfinzi (durvalumab) in combination with chemotherapy has been approved in the US for the treatment of adult...
AstraZeneca Imfinzi gets USFDA priority review for limited-stage small cell lung cancer Ruchika Sharma16 Aug 2024 12:30 PM ISTCambridge: AstraZeneca's supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), based on the results from the positive...
Merck discontinues Phase 3 trial for lung cancer combo drug Ruchika Sharma11 Aug 2024 10:00 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the Phase 3 KeyVibe-008 trial based on...
Insufficient evidence to recommend low-dose CT screening in never smokers lung cancer screening, finds research Dr. Kamal Kant Kohli7 Aug 2024 3:15 AM ISTLung cancer remains the leading cause of cancer-related deaths worldwide. Detecting this disease in its early stages significantly improves survival...
EMA Committee recommends Rybrevant in combo with chemotherapy for adult patients with lung cancer after failure of prior therapy Ruchika Sharma4 Aug 2024 11:00 AM ISTBeerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the Committee for Medicinal Products for Human Use...
